Allergic responses occur in humans, rodents, non-human primates, avian species, and all of the domestic animals. These responses are mediated by immunoglobulin E (IgE) antibodies that bind to mast cells and cause release/synthesis of potent mediators. Clinical syndromes include naturally occurring asthma in humans and cats; atopic dermatitis in humans, dogs, horses, and several other species; food allergies; and anaphylactic shock. Experimental induction of asthma in mice, rats, monkeys, sheep, and cats has helped to reveal mechanisms of pathogenesis of asthma in humans. All of these species share the ability to develop a rapid and often fatal response to systemic administration of an allergen—anaphylactic shock. Genetic predisposition to development of allergic disease (atopy) has been demonstrated in humans, dogs, and horses. Application of mouse models of IgE-mediated allergic asthma has provided evidence for a role of air pollutants (ozone, diesel exhaust, environmental tobacco smoke) in enhanced sensitization to allergens.

Keyword(s): anaphylaxisanimal modelsasthmaIgE

Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Murphy K. 2012. Allergy and allergic diseases. Janeway’s Immunobiology, 8th Edition, Murphy K, Geha R, Notarangelo L. 571–97 London/New York: Garland Sci., Taylor & Francis [Google Scholar]
  2. Pawankar R, Canonica GW, Holgate ST, Lockey RF. 2011. WAO White Book on Allergy 2011–2012: Executive Summary Milwaukee, WI: World Allergy Organ. [Google Scholar]
  3. Dykewicz MS, Hamilos DL. 2010. Rhinitis and sinusitis. J. Allergy Clin. Immunol. 125:2Suppl. 2S103–15 [Google Scholar]
  4. James WD, Berger T, Elston D. 2005. Andrews’ Diseases of the Skin: Clinical Dermatology Philadelphia: Saunders, 10th ed.150 pp [Google Scholar]
  5. Lemanske RF, Busse WW. 2010. Asthma: clinical expression and molecular mechanisms. J. Allergy Clin. Immunol. 125:2Suppl. 2S95–102 [Google Scholar]
  6. Ishizaka K, Ishizaka T, Hornbrook MM. 1966. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J. Immunol. 97:175–85 [Google Scholar]
  7. Tizard IR. 2009. Type I hypersensitivity. Veterinary Immunology: An Introduction,329–46 St. Louis, MO: Saunders/Elsevier, 8th ed. [Google Scholar]
  8. Djuardi Y, Supali T, Wibowo H, Kruize YC, Versteeg SA et al. 2013. The development of TH2 responses from infancy to 4 years of age and atopic sensitization in areas endemic for helminth infections. Allergy Asthma Clin. Immunol. 9:113 [Google Scholar]
  9. Kim KH, Jahan SA, Kabir E. 2013. A review on human health perspective of air pollution with respect to allergies and asthma. Environ. Int. 59:41–52 [Google Scholar]
  10. Finkelman FD. 2007. Anaphylaxis: lessons from mouse models. J. Allergy Clin. Immunol. 120:3506–15 quiz 516–17 [Google Scholar]
  11. Lehrer SB, Bozelka BE. 1982. Mouse IgE. Prog. Allergy 32:8–51 [Google Scholar]
  12. Martin RA, Hodgkins SR, Dixon AE, Poynter ME. 2014. Aligning mouse models of asthma to human endotypes of disease. Respirology 19:823–33 [Google Scholar]
  13. Al Heialy S, Mcgovern TK, Martin JG. 2011. Insights into asthmatic airway remodelling through murine models. Respirology 16:4589–97 [Google Scholar]
  14. Osebold JW, Zee YC, Gershwin LJ. 1988. Enhancement of allergic lung sensitization in mice by ozone inhalation. Proc. Soc. Exp. Biol. Med. 188:3259–64 [Google Scholar]
  15. Seymour BW, Pinkerton KE, Friebertshauser KE, Coffman RL, Gershwin LJ. 1997. Second-hand smoke is an adjuvant for T helper-2 responses in a murine model of allergy. J. Immunol. 159:126169–75 [Google Scholar]
  16. Mitchell VL, Gershwin LJ. 2007. Progesterone and environmental tobacco smoke act synergistically to exacerbate the development of allergic asthma in a mouse model. Clin. Exp. Allergy 37:2276–86 [Google Scholar]
  17. Haczku A, Chung KF, Sun J, Barnes PJ, Kay AB, Moqbel R. 1995. Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. Immunology 85:4598–603 [Google Scholar]
  18. Shimizu H, Obase Y, Katoh S, Mouri K, Kobashi Y, Oka M. 2013. Critical role of interleukin-5 in the development of a mite antigen-induced chronic bronchial asthma model. Inflamm. Res. 62:10911–17 [Google Scholar]
  19. Baron RM, Choi AJ, Owen CA, Choi AM. 2012. Genetically manipulated mouse models of lung disease: potential and pitfalls. Am. J. Physiol. Lung Cell. Mol. Physiol. 302:6L485–97 [Google Scholar]
  20. Izuhara K, Arima K, Kanaji S, Ohta S, Kanaji T. 2006. IL-13: a promising therapeutic target for bronchial asthma. Curr. Med. Chem. 13:192291–98 [Google Scholar]
  21. Gershwin LJ, Osebold JW, Zee YC. 1981. Immunoglobulin E-containing cells in mouse lung following allergen inhalation and ozone exposure. Int. Arch. Allergy Appl. Immunol. 65:3266–77 [Google Scholar]
  22. Halpern GM, Gershwin LJ, Gonzales G, Fowler ME. 1989. Diagnosis of inhalant allergy in a chimpanzee using “in vivo” and “in vitro” tests. Allergol. Immunopathol. 17:5271–76 [Google Scholar]
  23. Sakaguchi M, Inouye S, Imaoka K, Miyazawa H, Hashimoto M et al. 1992. Measurement of serum IgE antibodies against Japanese cedar pollen (Cryptomeria japonica) in Japanese monkeys (Macaca fuscata) with pollinosis. J. Med. Primatol. 21:6323–27 [Google Scholar]
  24. Patterson R, Harris KE. 1992. IgE-mediated rhesus monkey asthma: natural history and individual animal variation. Int. Arch. Allergy Immunol. 97:2154–59 [Google Scholar]
  25. Coffman RL, Hessel EM. 2005. Nonhuman primate models of asthma. J. Exp. Med. 201:121875–79 [Google Scholar]
  26. Bree A, Schlerman FJ, Wadanoli M, Tchistiakova L, Marquette K et al. 2007. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. J. Allergy Clin. Immunol. 119:51251–57 [Google Scholar]
  27. Schelegle ES, Gershwin LJ, Miller LA, Fanucchi MV, Van Winkle LS et al. 2001. Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae). Am. J. Pathol. 158:1333–41 [Google Scholar]
  28. Yasue M, Nakamura S, Yokota T, Okudaira H, Okumura Y. 1998. Experimental monkey model sensitized with mite antigen. Int. Arch. Allergy Immunol. 115:4303–11 [Google Scholar]
  29. Van Scott MR, Hooker JL, Ehrmann D, Shibata Y, Kukoly C et al. 2004. Dust mite-induced asthma in cynomolgus monkeys. J. Appl. Physiol. 96:41433–44 [Google Scholar]
  30. Fanucchi MV, Schelegle ES, Baker GL, Evans MJ, McDonald RJ et al. 2004. Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys. Am. J. Respir. Crit. Care Med. 170:111153–57 [Google Scholar]
  31. Plopper CG, Joad JP, Miller LA, Schelegle ES, Fanucchi MV et al. 2012. Lung effects of inhaled corticosteroids in a rhesus monkey model of childhood asthma. Clin. Exp. Allergy 42:71104–18 [Google Scholar]
  32. Fanucchi MV, Plopper CG, Evans MJ, Hyde DM, Van Winkle LS et al. 2006. Cyclic exposure to ozone alters distal airway development in infant rhesus monkeys. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:4L644–50 [Google Scholar]
  33. Joad JP, Kott KS, Bric JM, Peake JL, Plopper CG et al. 2006. Structural and functional localization of airway effects from episodic exposure of infant monkeys to allergen and/or ozone. Toxicol. Appl. Pharmacol. 214:3237–43 [Google Scholar]
  34. Gershwin LJ. 2001. Immunoglobulin E-mediated hypersensitivity in food-producing animals. Vet. Clin. N. Am. Food Anim. Pract. 17:3599–619 [Google Scholar]
  35. Gershwin LJ. 2009. Bovine immunoglobulin E. Vet. Immunol. Immunopathol. 132:12–6 [Google Scholar]
  36. Olchowy TW, Gershwin LJ, Dean DF. 1995. Allergic rhinitis in a herd of cattle. J. Am. Vet. Med. Assoc. 207:91211–14 [Google Scholar]
  37. Beadle GG, Pay TW. 1975. Reaginic antibody in cattle hypersensitised by foot-and-mouth disease vaccine. Res. Vet. Sci. 19:11–7 [Google Scholar]
  38. Black L, Pay TW. 1975. The evaluation of hypersensitivity tests in cattle after foot-and-mouth disease vaccination. J. Hyg. 74:2169–81 [Google Scholar]
  39. Francis MJ, Black L. 1986. Separation and characterization of potential allergens from cultured baby hamster kidney cells. Clin. Allergy 16:4371–77 [Google Scholar]
  40. Moazenijula G, Jabbari AR, Geravand MM, Banihashemi R, Hajizadeh A. 2011. Improvement of trivalent leptospira vaccine by removal of anaphylactic agents. Trop. Anim. Health Prod. 43:81471–74 [Google Scholar]
  41. Conlon JA, Shewen PE. 1993. Clinical and serological evaluation of a Pasteurella haemolytica A1 capsular polysaccharide vaccine. Vaccine 11:7767–72 [Google Scholar]
  42. Piercy DW. 1970. Anaphylaxis in young calves inoculated with heat-inactivated Mycoplasma mycoides. Res. Vet. Sci. 11:5481–83 [Google Scholar]
  43. Thatcher EF, Gershwin LJ, Baker NF. 1989. Levels of serum IgE in response to gastrointestinal nematodes in cattle. Vet. Parasitol. 32:2–3153–61 [Google Scholar]
  44. Ruby KW, Griffith RW, Gershwin LJ, Kaeberle ML. 2000. Haemophilus somnus-induced IgE in calves vaccinated with commercial monovalent H. somnus bacterins. Vet. Microbiol. 76:4373–83 [Google Scholar]
  45. Gershwin LJ, Schelegle ES, Gunther RA, Anderson ML, Woolums AR et al. 1998. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine 16:11–121225–36 [Google Scholar]
  46. Kalina WV, Woolums AR, Berghaus RD, Gershwin LJ. 2004. Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle. Vaccine 22:11–121465–74 [Google Scholar]
  47. Kalina WV, Anderson ML, Gershwin LJ. 2006. Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production. Comp. Immunol. Microbiol. Infect. Dis. 29:2–3138–56 [Google Scholar]
  48. Gershwin LJ, Himes SR, Dungworth DL, Giri SN, Friebertshauser KE, Camacho M. 1994. Effect of bovine respiratory syncytial virus infection on hypersensitivity to inhaled Micropolyspora faeni. Int. Arch. Allergy Immunol. 104:179–91 [Google Scholar]
  49. Gershwin LJ, Gunther RA, Anderson ML, Woolums AR, McArthur-Vaughan K et al. 2000. Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves. Am. J. Vet. Res. 61:3291–98 [Google Scholar]
  50. Gershwin LJ, Berghaus LJ, Arnold K, Anderson ML, Corbeil LB. 2005. Immune mechanisms of pathogenetic synergy in concurrent bovine pulmonary infection with Haemophilus somnus and bovine respiratory syncytial virus. Vet. Immunol. Immunopathol. 107:1–2119–30 [Google Scholar]
  51. Corbeil LB, Arnold KF, Kimball R, Berghaus L, Gershwin LJ. 2006. Specificity of IgG and IgE antibody responses to Haemophilus somnus infection of calves. Vet. Immunol. Immunopathol. 113:1–2191–99 [Google Scholar]
  52. Eyre P, Lewis AJ, Wells PW. 1973. Acute systemic anaphylaxis in the calf. Br. J. Pharmacol. 47:3504–16 [Google Scholar]
  53. Dorchies P. 1997. Comparative physiopathology of Oestrus ovis (Linne 1761) myiasis in man and animals. Bull. Acad. Natl. Med. 181:4673–83 discussion 683–84 [Google Scholar]
  54. Angulo-Valadez CE, Ascencio F, Jacquiet P, Dorchies P, Cepeda-Palacios R. 2011. Sheep and goat immune responses to nose bot infestation: a review. Med. Vet. Entomol. 25:2117–25 [Google Scholar]
  55. Abraham WM. 2008. Modeling of asthma, COPD and cystic fibrosis in sheep. Pulm. Pharmacol. Ther. 21:5743–54 [Google Scholar]
  56. Van Gramberg JL, de Veer MJ, O'Hehir RE, Meeusen EN, Bischof RJ. 2012. Induction of allergic responses to peanut allergen in sheep. PLOS ONE 7:12e51386 [Google Scholar]
  57. Bischof RJ, Snibson K, Shaw R, Meeusen EN. 2003. Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite. Clin. Exp. Allergy 33:3367–75 [Google Scholar]
  58. Shaw R, Pfeffer A, Bischof R. 2009. Ovine IgE and its role in immunological protection and disease. Vet. Immunol. Immunopathol. 132:131–40 [Google Scholar]
  59. Schmied J, Rupa P, Garvie S, Wilkie B. 2013. Immune response phenotype of allergic versus clinically tolerant pigs in a neonatal swine model of allergy. Vet. Immunol. Immunopathol. 154:1–217–24 [Google Scholar]
  60. Thomas DJ, Husmann RJ, Villamar M, Winship TR, Buck RH, Zuckermann FA. 2011. Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model. PLOS ONE 6:21 [Google Scholar]
  61. Sipos W, Reutterer B, Frank M, Unger H, Grassauer A et al. 2013. Escin inhibits type I allergic dermatitis in a novel porcine model. Int. Arch. Allergy Immunol. 161:144–52 [Google Scholar]
  62. Rupa P, Schmied J, Wilkie BN. 2009. Porcine allergy and IgE. Vet. Immunol. Immunopathol. 132:141–45 [Google Scholar]
  63. Rupa P, Schmied J, Wilkie BN. 2011. Prophylaxis of experimentally induced ovomucoid allergy in neonatal pigs using Lactococcus lactis. Vet. Immunol. Immunopathol. 140:1–223–29 [Google Scholar]
  64. Turnquist SE, Bouchard G, Fischer JR. 1993. Naturally occurring systemic anaphylactic and anaphylactoid reactions in four groups of pigs injected with commercially available bacterins. J. Vet. Diagn. Investig. 5:103–5 [Google Scholar]
  65. Wagner B. 2009. IgE in horses: occurrence in health and disease. Vet. Immunol. Immunopathol. 132:121–30 [Google Scholar]
  66. Pirie RS. 2014. Recurrent airway obstruction: a review. Equine Vet. J. 46:3276–88 [Google Scholar]
  67. Tahon L, Baselgia S, Gerber V, Doherr MG, Straub R et al. 2009. In vitro allergy tests compared to intradermal testing in horses with recurrent airway obstruction. Vet. Immunol. Immunopathol. 127:1–285–93 [Google Scholar]
  68. Lanz S, Gerber V, Marti E, Rettmer H, Klukowska-Rötzler J et al. 2013. Effect of hay dust extract and cyathostomin antigen stimulation on cytokine expression by PBMC in horses with recurrent airway obstruction. Vet. Immunol. Immunopathol. 155:4229–37 [Google Scholar]
  69. Neuhaus S, Bruendler P, Frey CF, Gottstein B, Doherr MG, Gerber V. 2010. Increased parasite resistance and recurrent airway obstruction in horses of a high-prevalence family. J. Vet. Intern. Med. 24:2407–13 [Google Scholar]
  70. Bründler P, Frey CF, Gottstein B, Nussbaumer P, Neuhaus S, Gerber V. 2011. Lower shedding of strongylid eggs by Warmblood horses with recurrent airway obstruction compared to unrelated healthy horses. Vet. J. 190:2e12–15 [Google Scholar]
  71. Gerber V, Baleri D, Klukowska-Rötzler J, Swinburne JE, Dolf G. 2009. Mixed inheritance of equine recurrent airway obstruction. J. Vet. Intern. Med. 23:3626–30 [Google Scholar]
  72. Klukowska-Rötzler J, Swinburne JE, Drögemüller C, Dolf G, Janda J et al. 2012. The interleukin 4 receptor gene and its role in recurrent airway obstruction in Swiss Warmblood horses. Anim. Genet. 43:4450–53 [Google Scholar]
  73. Andersson LS, Swinburne JE, Meadows JR, Broström H, Eriksson S et al. 2012. The same ELA class II risk factors confer equine insect bite hypersensitivity in two distinct populations. Immunogenetics 64:3201–8 [Google Scholar]
  74. Vychodilova L, Matiasovic J, Bobrova O, Futas J, Klumplerova M et al. 2013. Immunogenomic analysis of insect bite hypersensitivity in a model horse population. Vet. Immunol. Immunopathol. 152:3–4260–68 [Google Scholar]
  75. Hamza E, Doherr MG, Bertoni G, Jungi TW, Marti E. 2007. Modulation of allergy incidence in Icelandic horses is associated with a change in IL-4-producing T cells. Int. Arch. Allergy Immunol. 144:4325–37 [Google Scholar]
  76. Hamza E, Akdis CA, Wagner B, Steinbach F, Marti E. 2013. In vitro induction of functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity. Clin. Exp. Allergy 43:8889–901 [Google Scholar]
  77. Wagner B, Miller WH Jr, Erb HN, Lunn DP, Antczak DF. 2009. Sensitization of skin mast cells with IgE antibodies to Culicoides allergens occurs frequently in clinically healthy horses. Vet. Immunol. Immunopathol. 132:153–61 [Google Scholar]
  78. Hinden S, Klukowska-Rötzler J, Janda J, Marti EI, Gerber V, Roosje PJ. 2012. Characterization of the inflammatory infiltrate and cytokine expression in the skin of horses with recurrent urticaria. Vet. Dermatol. 23:6503–e99 [Google Scholar]
  79. Eyre P, Lewis AJ. 1973. Acute systemic anaphylaxis in the horse. Br. J. Pharmacol. 48:3426–37 [Google Scholar]
  80. Gershwin LJ, Netherwood KA, Norris MS, Behrens NE, Shao MX. 2012. Equine IgE responses to non-viral vaccine components. Vaccine 30:527615–20 [Google Scholar]
  81. Breukink HJ, Eysker M. 1995. Intravenous administration of Ivomec in horses. Tijdschr. Diergeneeskd. 120:4113–14 [Google Scholar]
  82. Nielsen IL, Jacobs KA, Huntington PJ, Chapman CB, Lloyd KC. 1988. Adverse reaction to procaine penicillin G in horses. Aust. Vet. J. 65:6181–85 [Google Scholar]
  83. Cosgrove SB, Wren JA, Cleaver DM, Walsh KF, Follis SI et al. 2013. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis. Vet. Dermatol. 24:6587–97 [Google Scholar]
  84. Royer CM, Rudolph K, Barrett EG. 2013. The neonatal susceptibility window for inhalant allergen sensitization in the atopically predisposed canine asthma model. Immunology 138:4361–69 [Google Scholar]
  85. Mandigers P, German AJ. 2010. Dietary hypersensitivity in cats and dogs. Tijdschr. Diergeneeskd. 135:19706–10 [Google Scholar]
  86. Shmuel DL, Cortes Y. 2013. Anaphylaxis in dogs and cats. J. Vet. Emerg. Crit. Care 23:4377–94 [Google Scholar]
  87. Reinero CR. 2009. Feline immunoglobulin E: historical perspective, diagnostics and clinical relevance. Vet. Immunol. Immunopathol. 132:113–20 [Google Scholar]
  88. Trzil JE, Reinero CR. 2014. Update on feline asthma. Vet. Clin. N. Am. Small Anim. Pract. 44:191–105 [Google Scholar]
  89. Reinero CR, DeClue AE, Rabinowitz P. 2009. Asthma in humans and cats: Is there a common sensitivity to aeroallegens in shared environments?. Environ. Res. 109:5634–40 [Google Scholar]
  90. Lee-Fowler TM, Guntur V, Dodam J, Cohn LA, DeClue AE, Reinero CR. 2012. The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma. Int. Arch. Allergy Immunol. 158:4369–74 [Google Scholar]
  91. Ravens PA, Xu BJ, Vogelnest LJ. 2014. Feline atopic dermatitis: a retrospective study of 45 cases (2001–2012). Vet. Dermatol. 25:295–102 e27–28 [Google Scholar]
  92. Bloom PB. 2006. Canine and feline eosinophilic skin diseases. Vet. Clin. N. Am. Small Anim. Pract. 36:141–60 [Google Scholar]
  93. Sykes JM 4th, Garner MM, Greer LL, Lung NP, Coke RL et al. 2007. Oral eosinophilic granulomas in tigers (Panthera tigris)—a collection of 16 cases. J. Zoo Wildl. Med. 38:2300–8 [Google Scholar]
  94. Gershwin LJ. 1978. The phylogenetic development of anaphylactic activity and homocytotropic antibodies. Dev. Comp. Immunol. 2:4595–615 [Google Scholar]
  95. Lynch NR, Turner KJ. 1974. Immediate hypersensitivity responses in the marsupial Setonix brachyurus (the quokka). Characterization of the homocytotropic antibody. Aust. J. Exp. Biol. Med. Sci. 52:5755–66 [Google Scholar]
  96. Frondoza CG, Levy DA. 1977. Anaphylaxis in chickens: evidence for in vivo and in vitro histamine release. Exp. Biol. Med. 156:436–40 [Google Scholar]
  97. Burns RB, Maxwell MH. 1981. Probable occurrence of IgE in the adult domestic fowl (Gallus domesticus) after horse serum stimulation. Vet. Res. Commun. 5:167–72 [Google Scholar]
  98. Chand N, Carlson HC, Eyre P. 1976. Passive cutaneous anaphylaxis in the domestic fowl. Int. Arch. Allergy Appl. Immunol. 51:508–17 [Google Scholar]
  99. Stringer EM, De Voe RS, Loomis MR. 2011. Suspected anaphylaxis to leuprolide acetate depot in two elf owls (Micrathene whitneyi). J. Zoo Wildl. Med. 42:1166–68 [Google Scholar]
  100. Jayaraman S, Muthukkaruppan VR. 1975. Manifestation of anaphylaxis to egg albumin in the lizard Caloides vercicolor. Experientia 31:121468–69 [Google Scholar]
  101. Cornelia M. 1928. Downs. VII. Active anaphylaxis in turtles. J. Immunol. 15:177–78 [Google Scholar]
  102. Gershwin LJ. 1981. Heterologous passive cutaneous anaphylaxis with bovine immunoglobulin E. Am. J. Vet. Res. 42:71184–87 [Google Scholar]
  103. Osebold JW, Gershwin LJ, Zee YC. 1980. Studies on the enhancement of allergic lung sensitization by inhalation of ozone and sulfuric acid aerosol. J. Environ. Pathol. Toxicol. 3:5–6221–34 [Google Scholar]
  104. Manners S, Alam R, Schwartz DA, Gorska MM. 2013. A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust. J. Allergy Clin. Immunol. 134:63–72 e7 [Google Scholar]
  105. Corson L, Zhu H, Quan C, Grunig G, Ballaney M et al. 2010. Prenatal allergen and diesel exhaust exposure and their effects on allergy in adult offspring mice. Allergy Asthma Clin. Immunol. 6:7 [Google Scholar]
  106. Alberg T, Cassee FR, Groeng EC, Dybing E, Løvik M. 2009. Fine ambient particles from various sites in Europe exerted a greater IgE adjuvant effect than coarse ambient particles in a mouse model. J. Toxicol. Environ. Health A 72:11–13 [Google Scholar]
  107. Gershwin LJ, Anderson ML, Wang C, Berghaus LJ, Kenny TP, Gunther RA. 2011. Assessment of IgE response and cytokine gene expression in pulmonary efferent lymph collected after ovalbumin inhalation during experimental infection of calves with bovine respiratory syncytial virus. Am. J. Vet. Res. 72:1134–45 [Google Scholar]
  108. Szabo SM, Levy AR, Gooch KL, Bradt P, Wijaya H, Mitchell I. 2013. Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr. Respir. Rev. 13:Suppl. 2S9–15 [Google Scholar]
  109. Han J, Takeda K, Gelfand EW. 2011. The role of RSV infection in asthma initiation and progression: findings in a mouse model. Pulm. Med. 2011:748038 [Google Scholar]

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error